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A preliminary validation of the method consisted of running three days of matrix-matched calibration curves and controls in replicate. The analytical range was specified at 1.0-100 ng/mL and verified analytically. Analysis of calibration statistics over three days demonstrated a slope of 0.999 and a bias of 0.05%. High, mid, and low controls were spiked at 80, 30, and 3 ng/mL. See Table 2 for precision and accuracy.
See Figure 4 for an example calibration curve and Figure 5 for an excerpt of the raw data showing chromatography.
The extraction and analytical method described were used to analyze a human whole blood sample sent for targeted toxicological analysis for MT-45, since both MT-45 and etizolam were identified in powders located in the residence of a decedent during an investigation. Quantitation was performed using the method of standard addition, and was performed on dilution due to the high concentration. A whole blood from the suspected overdose contained MT-45 at a concentration of 520 ng/mL, consistent with the concentrations reported in other deaths. Etizolam was also present in this case at a concentration of 35 ng/mL.
Due to the novel nature of these new synthetic substances, there is often very little available data regarding effects, toxicity, and pharmacodynamic profile, especially when compounds first appear on the drug market. Most information regarding these new substances derive from case reports, such as this case. This case also highlights the importance of thorough investigation, as the identification of the solid material allowed a targeted analysis to be performed for these novel substances which are not included in the routine scope of testing for death investigation casework.
The authors are grateful to Dr. Elizabeth Bundock of the OCME in Burlington, VT for providing investigative information in this case. Internet suppliers and retailers sell MT-45 in its dihydrochloride salt form. It has typically been seized as a white or brown powder, and occasionally in tablet form. It has also been seized in combination with other drugs, including heroin, synthetic cannabinoids, pyrrolidinophenones such as alpha-PBP, benzofurans such as 6-APDB, and synthetic cathinones such as methylone. Typical routes of administration include oral, insufflation, intravenous, and intramuscular, with varying reported doses.
NPS use had been detected in all types of forensic cases, including postmortem investigations. MT-45 has been identified in both postmortem and human performance toxicology casework in Sweden and has been linked to 33 adverse events, including 21 deaths. In these fatalities occurring in 2013 and 2014, the concentration of MT-45 in post-mortem femoral blood ranged from 60 to 1900 ng/mL. In 17 of the reported cases, MT-45 was found in combination with at least one other psychoactive substance.
This poster describes an analytical method for the identification and quantitation of MT-45 in human whole blood. Using the described methods, the analysis was used on human whole blood samples obtained in a death which was ultimately attributed to combined toxicity of MT-45 and the designer benzodiazepine, etizolam. 
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